Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

DOI Web Site Web Site 1 Citations

Journal

Citations (1)*help

See more

Report a problem

Back to top